ReviewEndocrine, metabolic & immune disorders drug targets2023

Tirzepatide: A New Generation Therapeutic for Diabetes Type 2.

Rami A Al-Horani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.